The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study)
Therapeutic control of the methotrexate (MT) polyglutamates (MTPG) level in erythrocytes can be an objective marker of the effective dose of MT prescribed for rheumatoid arthritis (RA).Objective: to assess the relationship between the level of MTPG in red blood cells and efficacy of the MT dose used...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2019-05-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2701 |
_version_ | 1797862635064000512 |
---|---|
author | G. I. Gridneva Yu. V. Muravyev N. V. Demidova E. S. Aronova A. V. Pivanova M. A. Borisova S. I. Glukhova A. S. Starkova N. M. Savushkina S. O. Krasnenko K. S. Nurbaeva N. V. Baimeeva I. A. Tyurin A. M. Lila |
author_facet | G. I. Gridneva Yu. V. Muravyev N. V. Demidova E. S. Aronova A. V. Pivanova M. A. Borisova S. I. Glukhova A. S. Starkova N. M. Savushkina S. O. Krasnenko K. S. Nurbaeva N. V. Baimeeva I. A. Tyurin A. M. Lila |
author_sort | G. I. Gridneva |
collection | DOAJ |
description | Therapeutic control of the methotrexate (MT) polyglutamates (MTPG) level in erythrocytes can be an objective marker of the effective dose of MT prescribed for rheumatoid arthritis (RA).Objective: to assess the relationship between the level of MTPG in red blood cells and efficacy of the MT dose used by RA patients.Subjects and methods. The study included 60 patients with RA (44 women and 16 men over 18 years) who met the criteria of the American College of Rheumatology and the European League Against Rheumatism (ACR/EULAR) 2010 and received MT ≥20 mg/week subcutaneously for ≥12 weeks. The patients were divided into two groups of comparable age, sex, alcohol intake, number of smokers, body mass index (BMI), depending on the presence (group 1; n=30) or absence (group 2; n=30) of the effect of MT, according to the EULAR efficacy criteria (DAS28). The concentration of MTPG (total MTPG and metabolites of MTPG 1, 2, 3, 4, 5) was determined in erythrocytes by high-performance liquid chromatography with mass spectrometric detection.Results and discussion. It was found that the levels of total MTPG and MTPG1, 2, 3, 5 in erythrocytes did not differ in groups of responders and nonresponders, and the dose of MT was comparable in both groups. At the same time, the level of MTPG4 in the first group was significantly higher (26.4±6.1 nmol/l; p=0.023) than in the second one (22.1±6.8 nmol/l). Analysis of the ROC curve showed that the values of MTPG4 <22.5 nmol/l corresponded to the absence of effect of MT. The area under the curve was 0.672 (95% confidence interval 0.536–0.808 (p=0.022), sensitivity 77%, specificity 53.3%.Conclusion. For effective treatment of patients with RA MT dose should provide MTPG4 level in red blood cells ≥22.5 nmol/l. |
first_indexed | 2024-04-09T22:22:33Z |
format | Article |
id | doaj.art-2c0097132dfd47aba6d2730b8cff2381 |
institution | Directory Open Access Journal |
issn | 1995-4484 1995-4492 |
language | Russian |
last_indexed | 2024-04-09T22:22:33Z |
publishDate | 2019-05-01 |
publisher | IMA PRESS LLC |
record_format | Article |
series | Научно-практическая ревматология |
spelling | doaj.art-2c0097132dfd47aba6d2730b8cff23812023-03-22T13:45:55ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922019-05-0157217117410.14412/1995-4484-2019-171-1742472The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study)G. I. Gridneva0Yu. V. Muravyev1N. V. Demidova2E. S. Aronova3A. V. Pivanova4M. A. Borisova5S. I. Glukhova6A. S. Starkova7N. M. Savushkina8S. O. Krasnenko9K. S. Nurbaeva10N. V. Baimeeva11I. A. Tyurin12A. M. Lila13V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaNational Center for Mental HealthAcute Poisoning Center for the Mentally Ill, N.V. Sklifosovsky Research Institute of Emergency CareV.A. Nasonova Research Institute of RheumatologyTherapeutic control of the methotrexate (MT) polyglutamates (MTPG) level in erythrocytes can be an objective marker of the effective dose of MT prescribed for rheumatoid arthritis (RA).Objective: to assess the relationship between the level of MTPG in red blood cells and efficacy of the MT dose used by RA patients.Subjects and methods. The study included 60 patients with RA (44 women and 16 men over 18 years) who met the criteria of the American College of Rheumatology and the European League Against Rheumatism (ACR/EULAR) 2010 and received MT ≥20 mg/week subcutaneously for ≥12 weeks. The patients were divided into two groups of comparable age, sex, alcohol intake, number of smokers, body mass index (BMI), depending on the presence (group 1; n=30) or absence (group 2; n=30) of the effect of MT, according to the EULAR efficacy criteria (DAS28). The concentration of MTPG (total MTPG and metabolites of MTPG 1, 2, 3, 4, 5) was determined in erythrocytes by high-performance liquid chromatography with mass spectrometric detection.Results and discussion. It was found that the levels of total MTPG and MTPG1, 2, 3, 5 in erythrocytes did not differ in groups of responders and nonresponders, and the dose of MT was comparable in both groups. At the same time, the level of MTPG4 in the first group was significantly higher (26.4±6.1 nmol/l; p=0.023) than in the second one (22.1±6.8 nmol/l). Analysis of the ROC curve showed that the values of MTPG4 <22.5 nmol/l corresponded to the absence of effect of MT. The area under the curve was 0.672 (95% confidence interval 0.536–0.808 (p=0.022), sensitivity 77%, specificity 53.3%.Conclusion. For effective treatment of patients with RA MT dose should provide MTPG4 level in red blood cells ≥22.5 nmol/l.https://rsp.mediar-press.net/rsp/article/view/2701methotrexatepolyglutamatestherapeutic controlrheumatoid arthritis |
spellingShingle | G. I. Gridneva Yu. V. Muravyev N. V. Demidova E. S. Aronova A. V. Pivanova M. A. Borisova S. I. Glukhova A. S. Starkova N. M. Savushkina S. O. Krasnenko K. S. Nurbaeva N. V. Baimeeva I. A. Tyurin A. M. Lila The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study) Научно-практическая ревматология methotrexate polyglutamates therapeutic control rheumatoid arthritis |
title | The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study) |
title_full | The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study) |
title_fullStr | The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study) |
title_full_unstemmed | The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study) |
title_short | The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study) |
title_sort | relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes pilot study |
topic | methotrexate polyglutamates therapeutic control rheumatoid arthritis |
url | https://rsp.mediar-press.net/rsp/article/view/2701 |
work_keys_str_mv | AT gigridneva therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT yuvmuravyev therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT nvdemidova therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT esaronova therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT avpivanova therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT maborisova therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT siglukhova therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT asstarkova therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT nmsavushkina therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT sokrasnenko therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT ksnurbaeva therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT nvbaimeeva therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT iatyurin therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT amlila therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT gigridneva relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT yuvmuravyev relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT nvdemidova relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT esaronova relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT avpivanova relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT maborisova relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT siglukhova relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT asstarkova relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT nmsavushkina relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT sokrasnenko relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT ksnurbaeva relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT nvbaimeeva relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT iatyurin relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy AT amlila relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy |